CUGBP2
From Wikipedia, the free encyclopedia
CUG triplet repeat, RNA binding protein 2
|
|||||||||||
PDB rendering based on 2cpz. | |||||||||||
Available structures: 2cpz | |||||||||||
Identifiers | |||||||||||
Symbol(s) | CUGBP2; BRUNOL3; ETR-3; NAPOR | ||||||||||
External IDs | OMIM: 602538 MGI: 1338822 HomoloGene: 4783 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 10659 | 14007 | |||||||||
Ensembl | ENSG00000048740 | ENSMUSG00000002107 | |||||||||
Refseq | NM_001025076 (mRNA) NP_001020247 (protein) |
NM_183219 (mRNA) NP_899042 (protein) |
|||||||||
Location | Chr 10: 11.25 - 11.42 Mb | Chr 2: 6.46 - 6.8 Mb | |||||||||
Pubmed search | [1] | [2] |
CUG triplet repeat, RNA binding protein 2, also known as CUGBP2, is a human gene.[1]
Members of the CELF/BRUNOL protein family contain two N-terminal RNA recognition motif (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 aa between the second and third RRM domains. Members of this protein family regulate pre-mRNA alternative splicing and may also be involved in mRNA editing, and translation. Alternative splicing results in multiple transcript variants encoding different isoforms.[1]
[edit] References
[edit] Further reading
- Hwang DM, Hwang WS, Liew CC (1995). "Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system.". J. Mol. Cell. Cardiol. 26 (10): 1329–33. doi: . PMID 7869393.
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791–806. PMID 8889548.
- Lu X, Timchenko NA, Timchenko LT (1999). "Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.". Hum. Mol. Genet. 8 (1): 53–60. PMID 9887331.
- Choi DK, Ito T, Tsukahara F, et al. (1999). "Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein.". Gene 237 (1): 135–42. PMID 10524244.
- Good PJ, Chen Q, Warner SJ, Herring DC (2000). "A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.". J. Biol. Chem. 275 (37): 28583–92. doi: . PMID 10893231.
- Ladd AN, Charlet N, Cooper TA (2001). "The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.". Mol. Cell. Biol. 21 (4): 1285–96. doi: . PMID 11158314.
- Li D, Bachinski LL, Roberts R (2001). "Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia.". Genomics 74 (3): 396–401. doi: . PMID 11414768.
- Anant S, Henderson JO, Mukhopadhyay D, et al. (2002). "Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.". J. Biol. Chem. 276 (50): 47338–51. doi: . PMID 11577082.
- Lichtner P, Attié-Bitach T, Schuffenhauer S, et al. (2003). "Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p.". J. Mol. Med. 80 (7): 431–42. doi: . PMID 12110949.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Mukhopadhyay D, Houchen CW, Kennedy S, et al. (2003). "Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2.". Mol. Cell 11 (1): 113–26. PMID 12535526.
- Singh G, Charlet-B N, Han J, Cooper TA (2004). "ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo.". Nucleic Acids Res. 32 (3): 1232–41. doi: . PMID 14973222.
- Mukhopadhyay D, Jung J, Murmu N, et al. (2004). "CUGBP2 plays a critical role in apoptosis of breast cancer cells in response to genotoxic injury.". Ann. N. Y. Acad. Sci. 1010: 504–9. PMID 15033780.
- Brandenberger R, Wei H, Zhang S, et al. (2005). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.". Nat. Biotechnol. 22 (6): 707–16. doi: . PMID 15146197.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.". Genome Res. 14 (9): 1711–8. doi: . PMID 15342556.
- Murmu N, Jung J, Mukhopadhyay D, et al. (2004). "Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage.". Proc. Natl. Acad. Sci. U.S.A. 101 (38): 13873–8. doi: . PMID 15358864.
- Han J, Cooper TA (2005). "Identification of CELF splicing activation and repression domains in vivo.". Nucleic Acids Res. 33 (9): 2769–80. doi: . PMID 15894795.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi: . PMID 16344560.
- Lim J, Hao T, Shaw C, et al. (2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.". Cell 125 (4): 801–14. doi: . PMID 16713569.
- Chen Z, Eggerman TL, Patterson AP (2007). "ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components.". Am. J. Physiol. Gastrointest. Liver Physiol. 292 (1): G53–65. doi: . PMID 16920700.